Inventor · disambiguated record
Peter Brooks
Also filed as: BROOKS PETER · BROOKS PETER C
37 granted patents·26 pending applications·604 citations·filing 1994–2024
97Inventor score
Top patents by PatentIndex Score
63 records- 0197US5766591AMethods and compositions useful for inhibition of angiogenesisSCRIPPS RESEARCH INST·Filed 1994·Granted Jun 16, 1998·159 cites·114 claims
- 0297US5753230AMethods and compositions useful for inhibition of angiogenesisSCRIPPS RESEARCH INST·Filed 1994·Granted May 19, 1998·196 cites·41 claims
- 0391US7566770B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2006·Granted Jul 28, 2009·12 cites·11 claims
- 0489US7365167B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2001·Granted Apr 29, 2008·21 cites·21 claims
- 0586US7588760B2Antagonists specific for denatured collagen and methods of using sameUNIV SOUTHERN CALIFORNIA·Filed 2008·Granted Sep 15, 2009·8 cites·9 claims
- 0686US7390885B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2001·Granted Jun 24, 2008·11 cites·21 claims
- 0785US8025883B2Antagonists and methods for inhibiting angiogenesisUNIV SOUTHERN CALIFORNIA·Filed 2005·Granted Sep 27, 2011·7 cites·12 claims
- 0885US7763247B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2008·Granted Jul 27, 2010·6 cites·9 claims
- 0984US7354586B2Methods of treating arthritis and diabetic retinopathy with αvβ3-specific antibodiesSCRIPPS RESEARCH INST·Filed 2004·Granted Apr 8, 2008·11 cites·24 claims
- 1083US7122635B2Method and composition for angiogenesis inhibitionUNIV SOUTHERN CALIFORNIA·Filed 2000·Granted Oct 17, 2006·16 cites·3 claims
- 1182US6500924B1Methods and compositions useful for inhibition of angiogenesisSCRIPPS RESEARCH INST·Filed 1997·Granted Dec 31, 2002·67 cites·6 claims
- 1280US8198328B2Treatment of cancer using benzoic acid derivativesBROOKS PETER C·Filed 2005·Granted Jun 12, 2012·3 cites·7 claims
- 1380US7566449B2Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrinsUNIV SOUTHERN CALIFORNIA·Filed 2005·Granted Jul 28, 2009·5 cites·24 claims
- 1479US7345151B2Antagonists specific for denatured collagen and methods of using sameUNIV SOUTHERN CALIFORNIA·Filed 2005·Granted Mar 18, 2008·3 cites·4 claims
- 1579US6887473B1Inhibition of angiogenesis in disease states with an anti-αvβ3 monoclonal antibodySCRIPPS RESEARCH INST·Filed 1998·Granted May 3, 2005·27 cites·63 claims
- 1677US7705049B2Methods for treating non-melanoma cancers with PABAUNIV NEW YORK·Filed 2005·Granted Apr 27, 2010·4 cites·3 claims
- 1777US7595051B2Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodiesSCRIPPS RESEARCH INST·Filed 2007·Granted Sep 29, 2009·1 cites·33 claims
- 1875US9890208B2Compositions and methods for treating inflammation and fibrosisMAINE MEDICAL CENTER·Filed 2014·Granted Feb 13, 2018·4 cites·10 claims
- 1974USD937535STree-shaped foodstuffKELLOG CO·Filed 2021·Granted Dec 7, 2021·5 cites·1 claims
- 2073US7763248B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2008·Granted Jul 27, 2010·1 cites·8 claims
- 2173US7101975B1Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrinsUNIV SOUTHERN CALIFORNIA·Filed 2000·Granted Sep 5, 2006·12 cites·17 claims
- 2268US7691905B2Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)UNIV NEW YORK·Filed 2003·Granted Apr 6, 2010·4 cites·4 claims
- 2367US7482007B2Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodiesSCRIPPS RESEARCH INST·Filed 2004·Granted Jan 27, 2009·1 cites·26 claims
- 2467US7329406B2Methods of treating psoriasis with αvβ3-specific antibodiesSCRIPPS RESEARCH INST·Filed 2004·Granted Feb 12, 2008·1 cites·11 claims
- 2562US7387998B2STQ peptidesUNIV NEW YORK·Filed 2004·Granted Jun 17, 2008·0 cites·3 claims
- 2661USD915729STree-shaped foodstuffKELLOG CO·Filed 2019·Granted Apr 13, 2021·7 cites·1 claims
- 2761US2006165703A1Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesisSCRIPPS RESEARCH INST·Filed 2005·Application pending·0 cites
- 2861US2024327506A1Methods and composition for the selective enhancement of adoptive cell therapyMaineHealth·Filed 2024·Application pending·0 cites
- 2961US2024358850A1Compositions and methods for an antibody drug conjugate directed to a non-cell surface therapeutic targetMaineHealth·Filed 2024·Application pending·0 cites
- 3060US2005123923A1Human obesity susceptibility gene and uses thereofFiled 2003·Application pending·0 cites
- 3160US2007154935A1Human obesity susceptibility gene and uses thereofINTEGRAGEN SA·Filed 2007·Application pending·0 cites
- 3259US7053041B1Methods and compositions useful for inhibition of αvβ5mediated angiogenesisSCRIPPS RESEARCH INST·Filed 1997·Granted May 30, 2006·9 cites·42 claims
- 3359US2010303726A1Humanized collagen antibodies and related methodsCELLMATRIX·Filed 2010·Application pending·0 cites
- 3459US2012121755A1Components for Animal Feed and Use ThereofBROOKS PETER·Filed 2010·Application pending·0 cites
- 3558US11998600B2Enhancing the therapeutic activity of an immune checkpoint inhibitorMaineHealth·Filed 2020·Granted Jun 4, 2024·0 cites·6 claims
- 3657US9018259B2Treatment of cancer using benzoic acid derivativesBROOKS PETER C·Filed 2012·Granted Apr 28, 2015·0 cites·2 claims
- 3755US2009226369A1STQ PeptidesUNIV NEW YORK·Filed 2008·Application pending·0 cites
- 3854US2013259844A1Fermented FoodstuffBROOKS PETER·Filed 2011·Application pending·0 cites
- 3953US2021155696A1Enhancing the therapeutic activity of immune checkpoint inhibitorMAINE MEDICAL CENTER RES INSTITUTE·Filed 2020·Application pending·0 cites
- 4053US2006270710A1Methods for inhibition of angiogenesisSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 4152US10881732B2Enhancing the therapeutic activity of an immune checkpoint inhibitorMAINE MEDICAL CENTER RES INSTITUTE·Filed 2016·Granted Jan 5, 2021·0 cites·6 claims
- 4250US10906977B2Enhancing the therapeutic activity of immune checkpoint inhibitorMAINE MEDICAL CENTER RES INSTITUTE·Filed 2017·Granted Feb 2, 2021·0 cites·6 claims
- 4349US2004063790A1Methods for inhibition of angiogenesisSCRIPPS RESEARCH INST·Filed 2003·Application pending·0 cites
- 4449US2003176334A1Methods and compositions useful for inhibition of angiogenesisSCRIPPS RESEARCH INST·Filed 2002·Application pending·0 cites
- 4549US2010323002A1Inhibition of melanogenesis and melanoma metastasis with p-amino benzoic acid (paba)UNIV NEW YORK·Filed 2010·Application pending·0 cites
- 4648US2015344839A1Components for Animal Feed and Use ThereofUNIV PLYMOUTH·Filed 2015·Application pending·0 cites
- 4748US2006240002A1Methods of inhibiting angiogenesis-dependent conditions mediated by cryptic epitopes of extracellular matrix componentsBROOKS PETER C·Filed 2006·Application pending·0 cites
- 4848US2006216237A1Inhibition of angiogenesis and tumor development by IGFBP-4BROOKS PETER C·Filed 2006·Application pending·0 cites
- 4945US7019108B2Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2UNIV SOUTHERN CALIFORNIA·Filed 2001·Granted Mar 28, 2006·0 cites·7 claims
- 5044US2008193464A1Human Autism Susceptibility Gene Encoding Prkcb1 and Uses ThereofPHILIPPI ANNE·Filed 2005·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Brooks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →